BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29298774)

  • 1. Kidney Transplantation in a Patient Lacking Cytosolic Phospholipase A
    Mitchell JA; Knowles RB; Kirkby NS; Reed DM; Edin ML; White WE; Chan MV; Longhurst H; Yaqoob MM; Milne GL; Zeldin DC; Warner TD
    Circ Res; 2018 Feb; 122(4):555-559. PubMed ID: 29298774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method.
    Mizugaki M; Hishinuma T; Matsumura E; Murai Y; Yamazaki T; Yamanobe S; Tamai M
    Prostaglandins Other Lipid Mediat; 1999 Nov; 58(5-6):253-62. PubMed ID: 10593167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabetic.
    Hishinuma T; Koseki Y; Murai Y; Yamazaki T; Suzuki K; Mizugaki M
    Prostaglandins Other Lipid Mediat; 1999 Nov; 58(5-6):263-71. PubMed ID: 10593168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2,3-Dinor metabolites of thromboxane A2 and prostacyclin in urine from healthy human subjects: diurnal variation and relation to 24h excretion.
    Wennmalm A; Benthin G; Granström EF; Persson L; Winell S
    Clin Sci (Lond); 1992 Oct; 83(4):461-5. PubMed ID: 1330409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive assessment of the cardiovascular eicosanoids, thromboxane A2 and prostacyclin, in randomly sampled males, with special reference to the influence of inheritance and environmental factors.
    Wennmalm A; Benthin G; Caidahl K; Granström EF; Lanne B; Persson L; Petersson AS; Winell S
    Clin Sci (Lond); 1990 Dec; 79(6):639-45. PubMed ID: 2176952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
    Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of prostacyclin and thromboxane biosynthesis in healthy volunteers by single and multiple doses of acetaminophen and indomethacin.
    Schwartz JI; Musser BJ; Tanaka WK; Taggart WV; Mehta A; Gottesdiener KM; Greenberg HE
    Clin Pharmacol Drug Dev; 2015 Sep; 4(5):337-45. PubMed ID: 27137142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.
    Belton O; Byrne D; Kearney D; Leahy A; Fitzgerald DJ
    Circulation; 2000 Aug; 102(8):840-5. PubMed ID: 10952950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age.
    Rångemark C; Benthin G; Granström EF; Persson L; Winell S; Wennmalm A
    Circulation; 1992 Nov; 86(5):1495-500. PubMed ID: 1423963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion of prostacyclin and thromboxane metabolites in threatened preterm labor: effect of indomethacin and nylidrin.
    Kurki T; Viinikka L; Ylikorkala O
    Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):150-4. PubMed ID: 1733190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.
    McAdam BF; Catella-Lawson F; Mardini IA; Kapoor S; Lawson JA; FitzGerald GA
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):272-7. PubMed ID: 9874808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excretion of thromboxane A2 and prostacyclin metabolites during treadmill exercise in patients with intermittent claudication.
    Wennmalm A; Edlund A; Sevastik B; FitzGerald GA
    Clin Physiol; 1988 Jun; 8(3):243-53. PubMed ID: 3402185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men.
    Wennmalm A; Benthin G; Granström EF; Persson L; Petersson AS; Winell S
    Circulation; 1991 May; 83(5):1698-704. PubMed ID: 2022025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative profiling of 6-ketoprostaglandin F1 alpha, 2,3-dinor-6-ketoprostaglandin F1 alpha, thromboxane B2 and 2,3-dinor-thromboxane B2 in human and rat urine by immunoaffinity extraction with gas chromatography-mass spectrometry.
    Chiabrando C; Pinciroli V; Campoleoni A; Benigni A; Piccinelli A; Fanelli R
    J Chromatogr; 1989 Oct; 495():1-11. PubMed ID: 2613794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
    Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
    Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence.
    Lin JS; Lui SM; Chen CM; Chang WC
    J Urol; 1992 Aug; 148(2 Pt 1):311-3. PubMed ID: 1635125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
    Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
    Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do prostacyclin and thromboxane contribute to the "protective effect" of pregnancies with chronic hypertension? A preliminary prospective longitudinal study.
    Moutquin JM; Lindsay C; Arial N; De Grandpré P; C-Gaudreault R; Forest JC; Massé J
    Am J Obstet Gynecol; 1997 Dec; 177(6):1483-90. PubMed ID: 9423755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane and prostacyclin formation in patients with deep vein thrombosis.
    Vesterqvist O; Gréen K; Johnsson H
    Thromb Res; 1987 Feb; 45(4):393-402. PubMed ID: 3554598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
    Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
    Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.